Ihor Bekersky

Safety, Tolerance, and Pharmacokinetics of High-Dose Liposomal Amphotericin B (AmBisome) in Patients Infected with<i>Aspergillus</i>Species and Other Filamentous Fungi: Maximum Tolerated Dose Study

Thomas J. Walsh, Jesse L. Goodman, Peter G. Pappas et al. · Antimicrobial Agents and Chemotherapy · 2001 · 401 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +17

Pharmacokinetics, Excretion, and Mass Balance of Liposomal Amphotericin B (AmBisome) and Amphotericin B Deoxycholate in Humans

Ihor Bekersky, Robert M. Fielding, Dawna Dressler et al. · Antimicrobial Agents and Chemotherapy · 2002 · 315 citations

Pharmacy, Pharmacokinetics, Pharmacology +14

Tacrolimus oral bioavailability doubles with coadministration of ketoconazole*

Leslie Carstensen Floren, Ihor Bekersky, Leslie Z. Benet et al. · Clinical Pharmacology & Therapeutics · 1997 · 267 citations

Medicine, Pharmacokinetics, Pharmacology +12

Biochemical site of regulation of bile acid biosynthesis in the rat

Sarah Shefer, Susan Hauser, Ihor Bekersky et al. · Journal of Lipid Research · 1970 · 248 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17

Plasma Protein Binding of Amphotericin B and Pharmacokinetics of Bound versus Unbound Amphotericin B after Administration of Intravenous Liposomal Amphotericin B (AmBisome) and Amphotericin B Deoxycholate

Ihor Bekersky, Robert M. Fielding, Dawna Dressler et al. · Antimicrobial Agents and Chemotherapy · 2002 · 233 citations

Pharmacy, Pharmacokinetics, Pharmacology +15